Similarity of fractionated versus single dose(s) of gemtuzumab ozogamicin as part of the MIDAM salvage regimen in relapsed/refractory acute myeloid leukemia patients
To the Editor:
Source: Seminars in Hematology - Category: Hematology Authors: Pierre Peterlin, Thierry Guillaume, Jacques Delaunay, Mohamad Mohty, Alice Garnier, Beatrice Mahe, Viviane Dubruille, Nicolas Blin, Maud Voldoire, Cyrille Touzeau, Cecile Chauvin, Thomas Gastinne, Marie C B éné, Steven Le Gouill, Philippe Moreau, Patric Tags: Letter to the Editor Source Type: research